Immobilization of O 2 -tolerant [NiFe] hydrogenase from Cupriavidus necator on Tin-rich Indium Oxide Alters the Catalytic Bias from H 2 Oxidation to Proton Reduction
ACS Catalysis · 05.05.2023 · 13 (9) · 6312-6327
DOI: 10.1021/acscatal.2c06334 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Catalysis, online erschienen am 24.04.2023. Verfasst von Victoria Davis und 12 weiteren Autor:innen. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: Albert-Ludwigs-Universit?t Freiburg, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Albert-Ludwigs-Universit?t Freiburg
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Davis, V., Heidary, N., Guiet, A., Ly, K. H., Zerball, M., Schulz, C., Michael, N., Klitzing, R. V., Hildebrandt, P., Frielingsdorf, S., Lenz, O., Zebger, I., & Fischer, A. (2023). Immobilization of O 2 -tolerant [NiFe] hydrogenase from Cupriavidus necator on Tin-rich Indium Oxide Alters the Catalytic Bias from H 2 Oxidation to Proton Reduction. ACS Catalysis, 13(9), 6312-6327. https://doi.org/10.1021/acscatal.2c06334
Vancouver
Davis V, Heidary N, Guiet A, Ly KH, Zerball M, Schulz C, et al. Immobilization of O 2 -tolerant [NiFe] hydrogenase from Cupriavidus necator on Tin-rich Indium Oxide Alters the Catalytic Bias from H 2 Oxidation to Proton Reduction. ACS Catalysis. 2023;13(9):6312-6327. doi:10.1021/acscatal.2c06334
BibTeX
@article{Davis2023,
author = {Davis, Victoria and Heidary, Nina and Guiet, Amandine and Ly, Khoa Hoang and Zerball, Maximilian and Schulz, Claudia and Michael, Norbert and Klitzing, Regine von and Hildebrandt, Peter and Frielingsdorf, Stefan and Lenz, Oliver and Zebger, Ingo and Fischer, Anna},
title = {Immobilization of O 2 -tolerant [NiFe] hydrogenase from Cupriavidus necator on Tin-rich Indium Oxide Alters the Catalytic Bias from H 2 Oxidation to Proton Reduction},
journal = {ACS Catalysis},
year = {2023},
volume = {13},
number = {9},
pages = {6312--6327},
doi = {10.1021/acscatal.2c06334}
}
EUVIMED